EDELMAN; Jeffrey L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for EDELMAN; Jeffrey L..The latest application filed is for "biodegradable intravitreal tyrosine kinase implants".

Company Profile

6.26.32

EDELMAN; Jeffrey L. - Irvine CA
Edelman; Jeffrey L. - Newport Beach CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biodegradable Intravitreal Tyrosine Kinase Implants App 20210121397 - EDELMAN; Jeffrey L. ; et al.	2021-04-29
Biodegradable intravitreal tyrosine kinase implants Grant 10,881,608 - Edelman , et al. January 5, 2	2021-01-05
Pharmaceutical Compositions And Methods Of Use Of 4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20190365786 - Edelman; Jeffrey L. ; et al.	2019-12-05
4-pregenen-11.beta.-17-21-triol-3,20-dione derivatives Grant 10,493,082 - Edelman , et al. De	2019-12-03
Biodegradable Intravitreal Tyrosine Kinase Implants App 20190038551 - Edelman; Jeffrey L. ; et al.	2019-02-07
Pharmaceutical compositions and methods of use of 4-pregenen-11.beta.-17-21-triol-3,20-dione derivatives Grant 10,188,667 - Edelman , et al. Ja	2019-01-29
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Grant 10,188,665 - Edelman , et al. Ja	2019-01-29
Biodegradable intravitreal tyrosine kinase implants Grant 10,076,492 - Edelman , et al. September 18, 2	2018-09-18
Pharmaceutical Compositions And Methods Of Use Of 4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20180147217 - Edelman; Jeffrey L. ; et al.	2018-05-31
Ocular Therapy Using Glucocorticoid Derivatives Selectively Penetrating Posterior Segment Tissues App 20180125861 - Edelman; Jeffrey L. ; et al.	2018-05-10
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Grant 9,820,995 - Edelman , et al. November 21, 2	2017-11-21
Pharmaceutical compositions and methods of use of 4-pregenen-11.beta.-17-21-triol-3,20-dione derivatives Grant 9,717,743 - Edelman , et al. August 1, 2	2017-08-01
4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20170182062 - Edelman; Jeffrey L. ; et al.	2017-06-29
4-pregenen-11.beta.-17-21-triol-3,20-dione derivatives Grant 9,433,631 - Edelman , et al. September 6, 2	2016-09-06
Biodegradable Intravitreal Tyrosine Kinase Implants App 20160199297 - Edelman; Jeffrey L. ; et al.	2016-07-14
Ocular Therapy Using Glucocorticoid Derivatives Selectively Penetrating Posterior Segment Tissues App 20160158249 - Edelman; Jeffrey L. ; et al.	2016-06-09
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Grant 9,259,429 - Edelman , et al. February 16, 2	2016-02-16
Biodegradable intravitreal tyrosine kinase implants Grant 9,233,070 - Edelman , et al. January 12, 2	2016-01-12
Steroid Containing Drug Delivery System App 20150265633 - Edelman; Jeffrey L. ; et al.	2015-09-24
3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors Grant 8,969,583 - Malone , et al. March 3, 2	2015-03-03
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Grant 8,968,766 - Hughes , et al. March 3, 2	2015-03-03
4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20150057258 - Edelman; Jeffrey L. ; et al.	2015-02-26
Pharmaceutical Compositions And Methods Of Use Of 4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20150005519 - Edelman; Jeffrey L. ; et al.	2015-01-01
4-pregenen-11.beta.-17-21-triol-3,20-dione derivatives Grant 8,906,892 - Edelman , et al. December 9, 2	2014-12-09
Ocular Therapy Using Glucocorticoid Derivatives Selectively Penetrating Posterior Segment Tissues App 20140357609 - Edelman; Jeffrey L. ; et al.	2014-12-04
Pharmaceutical compositions and methods of use 4-pregenen-11.beta.-17-21-triol-3,20-dione derivatives Grant 8,865,691 - Edelman , et al. October 21, 2	2014-10-21
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Grant 8,840,872 - Edelman , et al. September 23, 2	2014-09-23
Biodegradable Intravitreal Tyrosine Kinase Implants App 20140031408 - Edelman; Jeffrey L. ; et al.	2014-01-30
Kinase Inhibitors App 20130267497 - Spada; Lon T. ; et al.	2013-10-10
Biodegradable intravitreal tyrosine kinase implants Grant 8,512,738 - Edelman , et al. August 20, 2	2013-08-20
Sustained Release Intraocular Implants Containing Tyrosine Kinase Inhibitors And Related Methods App 20130210862 - Hughes; Patrick M. ; et al.	2013-08-15
3-phenyl-5-ureidoisothiazole-4-carboximide And 3-amino-5-phenylisothiazole Derivatives As Kinase Inhibitors App 20130172353 - Malone; Thomas C. ; et al.	2013-07-04
Kinase inhibitors Grant 8,455,656 - Spada , et al. June 4, 2	2013-06-04
Pharamceutical Compositions And Methods Of Use 4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20130123226 - Edelman; Jeffrey L. ; et al.	2013-05-16
4-pregenen-11beta-17-21-triol-3,20-dione Derivatives App 20130123223 - Edelman; Jeffrey L. ; et al.	2013-05-16
Kinase inhibitors Grant 8,383,825 - Spada , et al. February 26, 2	2013-02-26
Kinase inhibitors App 20120238558 - Spada; Lon T. ; et al.	2012-09-20
Kinase Inhibitors App 20120207810 - SPADA; Lon T. ; et al.	2012-08-16
Kinase inhibitors Grant 8,143,410 - Spada , et al. March 27, 2	2012-03-27
Ocular Therapy Using Glucocorticoid Derivatives Selectively Penetrating Posterior Segment Tissues App 20120065178 - Edelman; Jeffrey L. ; et al.	2012-03-15
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Grant 8,062,657 - Edelman , et al. November 22, 2	2011-11-22
Kinase Inhibitors App 20110263611 - Spada; Lon T. ; et al.	2011-10-27
Steroid Containing Drug Delivery Systems App 20110077229 - Edelman; Jeffrey L. ; et al.	2011-03-31
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Grant 7,771,742 - Hughes , et al. August 10, 2	2010-08-10
Kinase inhibitors Grant 7,749,530 - Spada , et al. July 6, 2	2010-07-06
Kinase inhibitors App 20090286773 - Spada; Lon T. ; et al.	2009-11-19
Kinase inhibitors App 20090208557 - Spada; Lon T. ; et al.	2009-08-20
Kinase inhibitors App 20090196906 - Spada; Lon T. ; et al.	2009-08-06
Steroid Containing Drug Delivery Systems App 20090082321 - EDELMAN; JEFFREY L. ; et al.	2009-03-26
Ocular Therapy Using Glucocorticoid Derivatives Selectively Penetrating Posterior Segment Tissues App 20070088014 - Edelman; Jeffrey L. ; et al.	2007-04-19
Anti-angiogenic sustained release intraocular implants and related methods App 20070059336 - Hughes; Patrick M. ; et al.	2007-03-15
Sustained release intraocular drug delivery systems App 20060182783 - Hughes; Patrick M. ; et al.	2006-08-17
Biodegradable intravitreal tyrosine kinase implants App 20050244475 - Edelman, Jeffrey L. ; et al.	2005-11-03
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods App 20050244470 - Hughes, Patrick M. ; et al.	2005-11-03